Copyright
©The Author(s) 2015.
World J Gastroenterol. Oct 21, 2015; 21(39): 10956-10981
Published online Oct 21, 2015. doi: 10.3748/wjg.v21.i39.10956
Published online Oct 21, 2015. doi: 10.3748/wjg.v21.i39.10956
ncRNA | Summary of findings/clinical relevance | q-PCR | Targets | Roles | Cases | Location | Ref. |
miR-141 | Reduced in metastasis positive tissues; Might be a prognostic marker and therapeutic target | √ | TAZ | Proliferation, invasion and migration | 36 GC vs paired adjacent tissues | China | [223] |
miR-874 | Reduced miR-874 promotes angiogenesis via STAT3; Might be a therapeutic target | √ | STAT3 | Tumor growth and angiogenesis | 80 GC vs paired adjacent tissues | China | [187] |
miR-101 | Lower level parallels with EZH2 overexpression | √ | EZH2 | E-cadherin dysfunction | 37 GC vs 5 normal gastric mucosa | Portugal | [224] |
miR-103a | Tumor suppressor by targeting c-Myb | √ | c-Myb | Proliferation, invasion and migration | 80 GC vs paired adjacent tissues | China | [225] |
miR-335 | Can be silenced by promoter hypermethylation which might be a predictive epigenetic marker and a therapeutic strategy | √ | RASA1 | Invasion and metastasis | 15 GC vs paired adjacent tissues | China | [52] |
miR-335 | Could be a therapeutic target for GC therapies and a prognostic factor | √ | Bcl-w, SP1 | Proliferation, invasion and metastasis | 70 GC vs paired adjacent tissues | China | [226] |
let-7a | A potential target for diagnosis and therapy | √ | RAB40C | Proliferation and colony formation | 27 GC vs paired adjacent tissues | China | [227] |
miR-490-3p | Reduced miR-490-3p reactivates SMARCD1 to confer malignant phenotypes | √ | SMARCD1 | Growth and metastasis | 14 GC vs 15 normal gastric tissues | Hong Kong | [228] |
miR-200c/141 | Reduced miRNA decreases ZEB1/2 expression and increases E-cadherin expression | √ | ZEB1/2 | Invasion and migration | 64 GC vs paired adjacent tissues | China | [229] |
miR-200b /c | Might be a marker of prognosis and therapeutic target | √ | DNMT3A, DNMT3B, SP1 | Proliferation, invasion and migration | 36 GC vs paired adjacent tissues | China | [230] |
miR-200 | Down-regulated miR-200 reduced E-cadherin expression, playing a role in the carcinogenesis of EBV-associated GC | √ | ZEB1, ZEB2 | Cell-to-cell adhesion and migration | 36 GC vs paired adjacent tissues (EBV-associated and EBV-negative) | Japan | [231] |
miR-204-5p | Restoration of miR-204-5p might provide a therapeutic strategy for GC | √ | USP47, RAB22A | Proliferation | 102 GC vs paired adjacent tissues | China | [232] |
miR-367 | A key negative regulator of invasion and metastasis of GC; Might be a therapeutic target | √ | Rab23 | Invasion and migration | 37 GC vs paired adjacent tissues | China | [233] |
miR-328 | MiR-328-mediated CD44 overexpression may associate with the carcinogenesis of GC | √ | CD44v9 | Survival and proliferation of metaplastic cells | 54 patients underwent gastric resection without preoperative treatment | Japan | [181] |
miR-328 | Macrophages mediated miR-328-CD44 signaling may be a therapeutic target for gastrointestinal cancer | √ | CD44 | Cell growth and drug resistance | 63 GC vs paired adjacent tissues | Japan | [234] |
miR-495 | A tumor suppressor and potential therapeutic target for GC peritoneal metastasis | √ | PRL-3 | Invasion and metastasis | 20 GC vs 10 normal gastric tissues | China | [53] |
miR-551a | A tumor suppressor targeting PRL-3 oncogene to inhibit GC cell migration and invasion | √ | PRL-3 | Invasion and migration | 30 malignant vs 4 normal gastric tissues | China | [235] |
miR-133b | A potential diagnostic marker and therapeutic target | √ | FSCN1 | Proliferation, invasion and migration | 100 GC vs paired adjacent tissues | China | [236] |
miR-542-3p | A tumor suppressor and a potential therapeutic target | √ | AEG-1 | Cell growth | 22 GC vs paired adjacent tissues | China | [112] |
miR-126 | Suppresses tumor growth and angiogenesis through targeting VEGF-A; A potential therapeutic target | √ | VEGF-A | Tumori-genicity and angiogenesis | 68 GC vs paired adjacent tissues | China | [119] |
miR-126 | May function as a tumor suppressor in GC | √ | Crk | Proliferation, cell cycle, apoptosis, invasion and migration | 60 GC vs paired adjacent tissues | China | [237] |
miR-29s | Increasing the expression of miR-29s may be a therapeutic strategy for GC | √ | AKT2 | Invasion | 20 GC vs paired adjacent tissues | China | [120] |
miR-29c | Reduced miR-29c expression is an early event in GC development; Potential diagnostic and therapeutic biomarkers | √ | ITGB1 | Proliferation, adhesion, invasion and migration | 274 GC vs paired adjacent tissues | South Korea, Japan, United States | [215] |
miR-29 family | Might be potential prognostic markers and therapeutic targets | √ | CCND2, MMP-2 | Proliferation apoptosis and invasion | 115 GC vs paired adjacent tissues | China | [238] |
miR-29c | Might be a tumor suppressor | √ | RCC2 | Proliferation and colony formation | 12 GC vs paired adjacent tissues | Japan | [239] |
miR-193b | Might be a potential prognostic marker | √ | Unknown | Differentiation and survival | 48 GC vs paired adjacent tissues | China | [240] |
miR-203 | Might be a therapeutic target for H. pylori infection induced GC | √ | CASK | Proliferation and invasion | 50 pairs of H. pylori positive and negative gastric tissues | China | [241] |
miR-210 | Epigenetic silencing of miR-210 involves in chronic H. pylori infection associated GC | √ | STMN1, DIMT1 | Proliferation | 20 GC vs paired adjacent tissues | Japan | [242] |
miR-34 family | Plays a role in the control of GC development | √ | Yin Yang 1 | Growth, colony formation, migration, invasion, and tumorsphere formation | 32 GC vs paired adjacent tissues | Taiwan | [243] |
miR-34b and | Down-regulated by hypermethylation of upstream CpG islands indicating a poor clinical outcome | √ | Unknown | Unknown | 72 GC vs paired adjacent tissues | Taiwan | [244] |
miR-129-3p | |||||||
miR-24 | A novel tumor suppressor and a potential therapeutic target | √ | RegIV | Proliferation, invasion and migration | 63 GC vs paired adjacent tissues | China | [245] |
miR-185 | Regulating the sensitivity of GC to chemotherapy | √ | ARC | Chemotherapeutic sensitivity | 25 GC vs paired adjacent tissues | China | [246] |
miR-1207-5p and miR-1266 | hTERT suppressors in GC and potential therapeutic targets | √ | hTERT | Cell growth, cell cycle and invasion | 58 GC vs adjacent tissues | China | [108] |
miR-365 | Playing a role in tumorigenesis; A potential therapeutic target | √ | Cyclin D1, cdc25A | Proliferation and colony formation | 127 GC vs paired adjacent tissues | China | [105] |
miR-760 | A potential prognostic predictor and therapeutic target | √ | Histone mRNA | Unknown | 53 bone marrow samples from stage IV patients vs 52 stage I patients; 22 stage IV GC vs 29 stage I GS tissues | Japan | [247] |
miR-143/145 | DDX6 contributes to the control of NCR143/145 RNA stability in P-bodies and post-transcriptionally regulated miR-143/145 expression | √ | Unknown | Cell survival, proliferation and malignant transformation | 14 GC tissues vs paired adjacent tissues | Japan | [84] |
miR-206 | A potential tumor suppressor and therapeutic target | √ | CyclinD2 | Proliferation, cell cycle and tumor growth | 30 primary GC vs paired distant tissues | China | [248] |
miR-204 | A potential target for preventive and therapeutic strategies | √ | Bcl-2 | Migration, colony forming and chemotherapy resistance | 92 gastric tumor specimens vs paired adjacent tissues | Italy | [249] |
miR-124 | A tumor suppressor; Play a role in miRNA-mediated SPHK1 expression | √ | SPHK1 | Proliferation and tumourigenicity | 20 GC vs paired adjacent tissues | China | [117] |
miR-409-3p | A tumor suppressor involving the direct targeting and inhibition of PHF10 | √ | PHF10 | Proliferation and apoptosis | 67 GC vs paired adjacent tissues | China | [250] |
miR-409-3p | Suppresses GC invasion and metastasis by directly targeting RDX; Reduced miR-409-3p is prone to lymph node metastasis | √ | RDX | Invasion and migration | 90 GC vs paired adjacent tissues | China | [251] |
miR-148a | Reduced miR-148a contributes to GC lymph node-metastasis and progression; A potential therapeutic target for GC metastasis | √ | ROCK1 | Invasion, migration and metastasis | 90 GC vs paired normal tissues | China | [252] |
miR-148b | A potential biomarker and therapeutic target | √ | CCKBR | Proliferation and tumorigenicity | 106 GC vs paired adjacent tissues | China | [253] |
miR-449 | A member of the miR-34 family playing an important role in GC | √ | GMNN, MET, CCNE2, SIRT1 | Cell cycle, proliferation and induce senescence | 10 GC vs paired adjacent tissues | Denmark | [254] |
miR-486 | A tumor-suppressor; Associated with the direct targeting and inhibition of OLFM4 | √ | OLFM4 | Proliferation, invasion and migration | 29 GC vs paired adjacent tissues | Singapore | [255] |
miR-142-5p | A potential predictor of progression and predict recurrence risk for GC | √ | MAPK, Wnt, VEGF | Recurrence risk related | 65 GC samples | China | [256] |
miR-125a-5p | Reduced miR-125a-5p is associated with enhanced malignant potential; A potential prognostic marker | √ | ERBB2 | Proliferation | 87 GC samples | Japan | [257] |
miR-516a-3p | An anti-metastamir with therapeutic potential in blocking metastatic dissemination of GC | √ | SULF1 | Proliferation, invasion and migration | 8 normal stomach tissues, 12 GC tissues from the patients with peritoneal dissemination and 12 GC tissues without peritoneal dissemination | Japan | [258] |
miR-181c | Silenced through methylation playing important roles in gastric carcinogenesis | √ | NOTCH4, and KRAS | Proliferation | 16 GC surgical specimens vs paired non-cancerous counterparts | Japan | [259] |
miR-212 | Reduced miR-212 may be related to gastric carcinogenesis | √ | MECP2 | Proliferation | 11 GC vs paired adjacent tissues | Japan | [260] |
miR-338-3p | MiR-338-3p inhibits the EMT progression in GC cells by targeting ZEB2 and MACC1/Met/Akt pathway | √ | ZEB2, MACC1 | Invasion and migration | 20 GC vs paired adjacent tissues | China | [261] |
miR-217 | A potential prognostic marker; miR-217-EZH2 axis may be a potential therapeutic target | √ | EZH2 | Proliferation, invasion and migration | 83 GC tissues vs adjacent tissues | China, United States | [262] |
miR-15a and miR-16-1 | MiR-15a and miR-16-1 have inhibitory effect providing a therapeutic potential in GC | √ | YAP1 | Proliferation, colony formation, invasion and migration | 60 GC vs paired adjacent tissues | Hong Kong | [263] |
ncRNA | Summary of findings/clinical relevance | q-PCR | Targets | Roles | Cases | Location | Ref. |
miR-23a/b | Implicated in the progression of GC. A potential prognosis marker | √ | Unknown | Unknown | 160 GC vs adjacent tissues | China | [264] |
miR-500 | Highly correlated with malignant progression and poor survival of GC | √ | CYLD, TAX1BP1, OTUD7B | Proliferation, survival and tumorigenicity | 10 GC vs adjacent tissues | China | [137] |
miR-374a | A promising therapeutic target | √ | SRCIN1 | Proliferation, tumor growth migration and invasion | 18 GC tissues vs adjacent tissues | China | [265] |
miR-199a-3p | A tumor promoter in GC targeting and inhibition of ZHX1; A potential target for GC prevention and therapy | √ | ZHX1 | Proliferation and apoptosis | 52 GC vs adjacent tissues | China | [266] |
miR-18a | A potential marker for risk stratification in the management of GC patients | √ | PIAS3, STAT3 | Unknown | 82 patients with GC and 65 healthy controls (plasma) | China | [204] |
miR-196a | A potential prognostic marker in GC | √ | Unknown | Differentiation and survival | 48 GC vs adjacent tissues | China | [240] |
miR-223, miR-16, miR-100 | Up-regulated in serum implicates their potential diagnostic value; Significantly elevated expression of the three miRNAs in advanced GC patients suggests their availability in cancer staging | √ | PIAS3 | Unknown | 50 GC patients and 47 healthy controls (serum) | China | [202] |
miR-135a-5p | Play a role in miRNA-135a-5p-AP-2α-BCL-2 pathway providing therapeutic potential for GC and solution for insensitivity of GC to chemotherapy | √ | AP-2α | Cell resistance to apoptosis, sensitivity to adriamycin | 20 GC vs adjacent tissues | China | [267] |
miR-199a-5p | SRF/miR-199a-5p/E-cadherin pathway promotes GC EMT and metastasis; A potential therapeutic target or biomarker for GC progression | √ | E-cadherin | Adhesion, invasion, and metastasis | 7 GC vs pairs adjacent tissues | China | [268] |
miR-25 | A potential biomarker for the prognosis of GC | √ | ERBB2, 1(TOB1) | Migration, invasion and proliferation | 33 GC vs paired adjacent tissues | China | [269] |
miR-942 | A potential drug response biomarker and therapeutic target for TRAIL resistant tumors | √ | ISG12a | Apoptosis | 28 GC tissues | China | [134] |
miR-196a/b | A potential therapeutic target in suppressing GC metastasis | √ | Radixin | Metastasis | 109 GC vs paired adjacent tissues | Taiwan | [172] |
miR-19a/b | A member of miR-19a/b facilitating GC cell migration, invasion and metastasis, implicating a novel mechanism for the malignant phenotypes of GC | √ | MXD1 | Migration and invasion | 141 GC vs paired adjacent tissues | China | [173] |
miR-423-5p | A potential therapeutic target | √ | TFF1 | Proliferation and invasion | 15 GC vs paired adjacent tissues | China | [270] |
miR-183-96-182 cluster | A novel role for GSK3β in the regulation of miR-183-96-182 biogenesis through β-catenin/TCF/ LEF-1 pathway in GC | √ | FoxO1 | Proliferation and migration | 8 GC vs paired adjacent tissues | United States | [83] |
miR-215 | Influencing cell proliferation by targeting RB1 | √ | RB1 | Proliferation | 51 GC vs paired adjacent tissues | China | [271] |
miR-17-92 cluster | Cluster including miR-19b, miR-20a and miR-92a associates with the development of GC stem cells; and miR-92a as a potential predictive prognostic marker for miR-92a in GC | √ | E2F1, HIPK1 | Self-renewal and proliferation | 97 GC specimens | China | [272] |
miR-296-5p | MiR-296-5p-CDX1-ERK1/2 axis play a role in gastric tumorigenesis; A potential therapeutic target | √ | CDX1 | Proliferation | 16 GC vs paired adjacent tissues | China | [273] |
miR-181a | Associated with increased risk and poor survival of GC | √ | MTMR3 | Unknown | 50 GC vs paired adjacent tissues | China | [274] |
miR-196a | Contributing to gastric carcinogenesis; A potential therapeutic target and prognostic factor | √ | p27 | Proliferation, apoptosis and tumorigenesis | 36 GC vs paired adjacent tissues | China | [275] |
miR-196b | Transcriptionally regulated by ETS2; A potential diagnostic marker and therapeutic target | √ | AnnexinA1, HOXB8 | Migration and invasion | 63 GC vs paired adjacent tissues | Taiwan | [276] |
miR-378 | Up-regulated in serum while down-regulated in GC tissues. A potential serum biomarker in GC detection | √ | Unknown | Unknown | 4 GC vs paired adjacent tissues, 40 GC serum samples vs 41 healthy controls | China | [277] |
miR-370 | Associated with GC progression by targeting TGFβ-RII | √ | TGFβ-RII | Migration | 33 GC vs adjacent tissues | Taiwan | [278] |
miR-192 miR-215 | Exerting cell growth and migration-promoting effects | √ | ALCAM | Migration, invasion, proliferation, cell cycle and apoptosis | 31 non-neoplastic stomach tissues and 25 GC tissues | United States | [279] |
miR-200b | A potential diagnostic and prognostic biomarker; A potential therapeutic target for peritoneal dissemination | √ | Unknown | Migration and invasion | 173 GC vs paired normal gastric epithelium tissues | Japan | [280] |
ncRNA | Summary of findings/clinical relevance | q-PCR | Targets | Roles | Cases | Location | Ref. |
miR-183 ↑ | A potential biomarker for GC progression and therapeutic target | √ | PDCD4 | Proliferation, migration, invasion, and apoptosis | 80 GC vs 20 non-tumorous gastric mucosa tissues | China | [131] |
miR-183 ↓ | A tumor suppressor partially through regulation of Ezrin; A potential therapeutic target | √ | Ezrin | Invasion | 52 pairs of paraffin-embedded GC and adjacent tissues; 5 fresh tissues samples from three patients | China | [281] |
miR-146a ↑ | A key factor in the regulation of NF-κB activity | √ | CARD10, COPS8 | Inhibits NF-κB activation | 37 GC vs paired adjacent tissues | Denmark | [282] |
miR-146a/b ↓ | MiR-146a/b/UHRF1 axis associates with the GC metastasis; A potential therapeutic target in blocking GC metastasis | √ | UHRF1 | Invasion and metastasis | 15 primary GC tissues compared with matched adjacent normal tissues | China | [180] |
miR-146a ↓ | MiR-146a/WASF2 axis may associate with the migration and invasion of GC cells; A potential therapeutic target | √ | WASF2 | Invasion and metastasis | 20 GC vs paired adjacent tissues | China | [283] |
miR-146a ↓ | Targeting EGFR and IRAK1; A potential prognostic factor | √ | EGFR, IRAK1 | Invasion and metastasis | 90 GC vs paired adjacent tissues | Japan | [179] |
miR-9 ↑ | Targeting and suppressing CDX2 expression promote GC cell proliferation | √ | CDX2 | Proliferation | 27 GC tissues | Japan | [284] |
miR-9 ↓ | Ectopic expression of miR-9 inhibits the proliferation, migration and invasion of GC cells | √ | MMP2, MMP9, Twist, N-cadherin | Invasion and metastasis | 72 GC vs adjacent tissues | Taiwan | [285] |
miR-9 ↓ | A tumor suppressor targeting NF-κB1 | √ | NF-κB1 | Proliferation | 9 GC vs paired adjacent tissues | China | [286] |
miR-375 ↑ | A predictor of GC; progression and recurrence risk for GC patients | √ | P53, MAPK, Wnt, VEGF | High frequency recurrence and poor survival | 34 frozen fresh tissues and 38 paraffin-embedded tissues | China | [256] |
miR-375 ↓ | A tumor suppressor; Playing a role in gastric tumorigenesis | √ | JAK2 | Proliferation | 48 GC vs paired adjacent tissues | China | [287] |
miR-375 ↓ | A tumor suppressor | √ | PDK1, 14-3-3zeta | Apoptosis, proliferation | 22 samples from GC and 5 normal control tissues | Japan | [288] |
miR-218-5p ↑ | MiR-218-5p targets and suppresses TFF1 and influences the progression of GC in an Erk1/2-dependent manner; A potential therapeutic target | √ | TFF1 | Proliferation | 42 GC vs paired adjacent tissues | China | [289] |
miR-218 ↓ | Disruption of Slit-miR-218-Robo1 regulatory circuit may contribute to GC metastasis. A potential therapeutic target in blocking GC metastasis | √ | Robo1 | Invasion and metastasis | 40 GC vs paired adjacent tissues | China | [290] |
- Citation: Yang Q, Zhang RW, Sui PC, He HT, Ding L. Dysregulation of non-coding RNAs in gastric cancer. World J Gastroenterol 2015; 21(39): 10956-10981
- URL: https://www.wjgnet.com/1007-9327/full/v21/i39/10956.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i39.10956